“They’re cutting our BUDs!” I heard this from an exasperated compounding pharmacist looking for any way to make the most out of his product’s shelf life. BUDs, or the Beyond-Use Dates assigned to compounded products, determine when a product must be destroyed if it has not yet been used. Wasted products are not good for business or patients.
The draft chapter for USP <797> “Pharmaceutical Compounding – Sterile Preparations” has been available for almost a year. The massive overhaul of the parameters used to assign Beyond-Use Dates should no longer be a surprise. In most cases, compounded products will have shorter shelf lives. This heavily impacts batch planning and availability to patients.
There are some ways to extend the BUDs that are outlined in the new revision. Most notably, performing a sterility test on each lot can often double the BUD window. But waiting for a sterility test takes at least two weeks, which significantly cuts into that window. Read more >
Charles River’s QC microbiology testing portfolio brings you modern products and services that deliver accurate, relevant, and reliable data to allow you to make confident decisions on your product quality and contamination control. Our unique combination of Endosafe® endotoxin testing, Celsis® rapid microbial detection, and Accugenix® microbial identification and strain typing keeps your manufacturing operations running efficiently and smoothly, lowers your cost to manufacture, and protects your reputation.
This post is related to:
Compounding: USP <795> Non-Sterile Resources, Compliance, Technology
